Contact this trialFirst, we need to learn more about you.
Selective Estrogen Receptor Modulator
Endoxifen for Estrogen Receptor-Positive Breast Cancer
Recruiting1 awardPhase 1
Rochester, Minnesota
This trial is testing the side effects and best dose of Z-endoxifen to treat patients with ER+ breast cancer. Z-endoxifen may fight breast cancer by blocking the use of estrogen by tumor cells.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service